AGENUS INC Payments to Acquire Businesses, Gross
AGENUS INC (AGEN) reported Payments to Acquire Businesses, Gross of $2.92 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2025-03-17
- AGENUS INC payments to acquire businesses, gross for the quarter ending 2022-12-31 was -$735.00K.
- AGENUS INC payments to acquire businesses, gross for the quarter ending 2022-09-30 was $0.00.
- AGENUS INC payments to acquire businesses, gross for the quarter ending 2022-06-30 was $650.00K.
- AGENUS INC payments to acquire businesses, gross for the quarter ending 2022-03-31 was $3.00M.
- AGENUS INC payments to acquire businesses, gross for fiscal 2022 was $2.92M.
- AGENUS INC payments to acquire businesses, gross for fiscal 2020 was $975.00K.
| Period end | Payments to Acquire Businesses, Gross 0 month | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 6 month as first filed | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | -$735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$735.00K derived: sum of 2 quarters · filed 2025-03-17 | -$85.00K derived: sum of 3 quarters · filed 2025-03-17 | $2.92M 10-K · filed 2025-03-17 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $650.00K derived: sum of 2 quarters · filed 2023-11-09 | $3.65M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.65M 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-09 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.00K derived: sum of 2 quarters · filed 2023-03-16 | $975.00K 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $975.00K 10-Q · filed 2021-11-09 | ||||
| 2020-06-30 | $972.00K 10-Q · filed 2021-08-09 | $1.00M 10-Q · filed 2020-08-10 | ||||
| 2015-12-23 | $2.50M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |